Tech Company Financing Transactions
Xsensio Funding Round
On 3/2/2026, Xsensio announced $7 million in Series A funding from WI Harper, European Innovation Council Fund and private investors.
Transaction Overview
Company Name
Announced On
3/2/2026
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
WI Harper (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the development and clinical validation of its Lab-on-Skin wearable biosensing platform.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
EPFL Innovation Park Building A
Lausanne, CH-1015
Switzerland
Lausanne, CH-1015
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
Xsensio S.A. is an innovation-driven Swiss company dedicated to solving one of the biggest challenges in healthcare & wellness: the lack of real-time, continuous monitoring of relevant health & wellness parameters. The company vision is to become the world leader in wearable biosensors and help billions of people around the world take better decisions throughout the day, thanks to data collected in a simple and minimally invasive way.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Esmeralda Megally
Browse more venture capital transactions:
Prev: 3/2/2026: Companion Labs venture capital transaction
Next: 3/2/2026: Five Bells venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs